Cargando…

What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 there remains an urgent need for pharmacologic therapies to treat infected patients, mini...

Descripción completa

Detalles Bibliográficos
Autores principales: Ottaviani, Silvia, Stebbing, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235589/
https://www.ncbi.nlm.nih.gov/pubmed/32838354
http://dx.doi.org/10.1016/j.medj.2020.04.002
_version_ 1783535990105702400
author Ottaviani, Silvia
Stebbing, Justin
author_facet Ottaviani, Silvia
Stebbing, Justin
author_sort Ottaviani, Silvia
collection PubMed
description The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 there remains an urgent need for pharmacologic therapies to treat infected patients, minimize mortality, and decrease pressures on intensive care units and health systems and optimally, they should also decrease subsequent transmission.
format Online
Article
Text
id pubmed-7235589
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-72355892020-05-19 What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials Ottaviani, Silvia Stebbing, Justin Med (N Y) Viewpoint The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest public health challenge to the biomedical community of the last century. Despite multiple public health measures,1, 2, 3 there remains an urgent need for pharmacologic therapies to treat infected patients, minimize mortality, and decrease pressures on intensive care units and health systems and optimally, they should also decrease subsequent transmission. Elsevier Inc. 2020-12-18 2020-05-19 /pmc/articles/PMC7235589/ /pubmed/32838354 http://dx.doi.org/10.1016/j.medj.2020.04.002 Text en © 2020 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Viewpoint
Ottaviani, Silvia
Stebbing, Justin
What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
title What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
title_full What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
title_fullStr What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
title_full_unstemmed What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
title_short What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials
title_sort what is the best drug to treat covid-19? the need for randomized controlled trials
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235589/
https://www.ncbi.nlm.nih.gov/pubmed/32838354
http://dx.doi.org/10.1016/j.medj.2020.04.002
work_keys_str_mv AT ottavianisilvia whatisthebestdrugtotreatcovid19theneedforrandomizedcontrolledtrials
AT stebbingjustin whatisthebestdrugtotreatcovid19theneedforrandomizedcontrolledtrials